Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis

Clinical Cancer Research

Volumn 9, Issue 7, 2003, Pages 2734-2743

  Ngo, Tung H ^a   Barnard, R James ^a   Cohen, Pinchas ^a   Freedland, Stephen ^a   Tran, Chris ^a   DeGregorio, Frank ^a   Elshimali, Yahya I ^a   Heber, David ^a   Aronson, William J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; INSULIN; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ARTICLE; ATHEROGENIC DIET; CALORIC INTAKE; CANCER CELL CULTURE; CANCER PREVENTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INJECTION; INSULIN BLOOD LEVEL; LOW CALORY DIET; LOW FAT DIET; MALE; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZATION; SCID MOUSE; SPECIES COMPARISON; TUMOR GROWTH; TUMOR VOLUME; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; BIOLOGICAL ASSAY; BLOTTING, WESTERN; CELL LINE, TUMOR; CULTURE MEDIA; DIET, FAT-RESTRICTED; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR I; KI-67 ANTIGEN; LIGANDS; MALE; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 0037816648     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Ries, L., Eisner, M., Kosary, C., Hankey, B., Miller, B., Clegg, L., and Edwards, B. SEER Cancer Statistics Review, 1973-1999. Bethesda, MD: National Cancer Institute, 2002.
2. Breslow, N., Chan, C. W., Dhom, G., Drury, R. A., Franks, L. M., Gellei, B., Lee, Y. S., Lundberg, S., Sparke, B., Sternby, N. H., and Tulinius, H. Latent carcinoma of prostate at autopsy in seven areas. Int. J. Cancer, 20: 680-688, 1977.
3. Akazaki, K., and Stemmerman, G. N. Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii. J. Natl. Cancer Inst. (Bethesda), 50: 1137-1144, 1973.
4. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1999. CA Cancer J. Clin., 49: 8-31, 1999.
5. Parkin, D. M., Pisani, P., and Ferlay, J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer, 80: 827-841, 1999.
6. Muir, C. S., Nectoux, J., and Staszewski, J. The epidemiology of prostatic cancer. Geographical distribution and time-trends. Acta Oncol., 30: 133-140, 1991.
7. Yatani, R., Kusano, I., Shiraishi, T., Hayashi, T., and Stemmermann, G. N. Latent prostatic carcinoma: pathological and epidemiological aspects. Jpn. J. Clin. Oncol., 19: 319-326, 1989.
8. Shimizu, H., Ross, R. K., Bernstein, L., Yatani, R., Henderson, B. E., and Mack, T. M. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br. J. Cancer, 63: 963-966, 1991.
9. Stellman, S. D., and Wang, Q. S. Cancer mortality in Chinese immigrants to New York City. Comparison with Chinese in Tianjin and with United States-born whites. Cancer, 73: 1270-1275, 1994.
10. Cook, L. S., Goldoft, M., Schwartz, S. M., and Weiss, N. S. Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J. Urol., 161: 152-155, 1999.
11. Whittemore, A. S., Kolonel, L. N., Wu, A. H., John, E. M., Gallagher, R. P., Howe, G. R., Burch, J. D., Hankin, J., Dreon, D. M., West, D. W., et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J. Natl. Cancer Inst. (Bethesda), 87: 652-661, 1995.
12. Fradet, Y., Meyer, F., Bairati, I., Shadmani, R., and Moore, L. Dietary fat and prostate cancer progression and survival. Eur. Urol., 35: 388-391, 1999.
13. Giovannucci, E., Rimm, E. B., Colditz, G. A., Stampfer, M. J., Ascherio, A., Chute, C. C., and Willett, W. C. A prospective study of dietary fat and risk of prostate cancer. J. Natl. Cancer Inst. (Bethesda), 85: 1571-1579, 1993.
14. West, D. W., Slattery, M. L., Robison, L. M., French, T. K., and Mahoney, A. W. Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control, 2: 85-94, 1991.
15. Pollard, M., and Luckert, P. H. Promotional effects of testosterone and high fat diet on the development of autochthonous prostate cancer in rats. Cancer Lett., 32: 223-227, 1986.
16. Kondo, Y., Homma, Y., Aso, Y., and Kakizoe, T. Promotional effect of two-generation exposure to a high-fat diet on prostate carcinogenesis in ACI/Seg rats. Cancer Res., 54: 6129-6132, 1994.
17. Wang, Y., Corr, J. G., Thaler, H. T., Tao, Y., Fair, W. R., and Heston, W. D. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J. Natl. Cancer Inst. (Bethesda), 87: 1456-1462, 1995.
18. Kritchevsky, D. Caloric restriction and cancer. J. Nutr. Sci. Vitaminol. (Tokyo), 47: 13-19, 2001.
19. Kritchevsky, D. Caloric restriction and experimental carcinogenesis. J. Toxicol. Sci., 52: 13-16, 1999.
20. Engelman, R. W., Day, N. K., Chen, R. F., Tomita, Y., Bauer-Sardina, I., Dao, M. L., and Good, R. A. Calorie consumption level influences development of C3H/Ou breast adenocarcinoma with indifference to calorie source. Proc. Soc. Exp. Biol. Med., 193: 23-30, 1990.
21. Pariza, M. W. Dietary fat, calorie restriction, ad libitum feeding, and cancer risk. Nutr. Rev., 45: 1-7, 1987.
22. Pandalai, P. K., Pilat, M. J., Yamazaki, K., Naik, H., and Pienta, K. J. The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth. Anticancer Res., 16: 815-820, 1996.
23. Yu, H., and Rohan, T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. (Bethesda), 92: 1472-1489, 2000.
24. Kaplan, P. J., Mohan, S., Cohen, P., Foster, B. A., and Greenberg, N. M. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Cancer Res., 59: 2203-2209, 1999.
25. Burfeind, P., Chernicky, C. L., Rininsland, F., and Ilan, J. Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc. Natl. Acad. Sci. USA, 93: 7263-7268, 1996.
26. Dunn, S. E., Kari, F. W., French, J., Leininger, J. R., Travlos, G., Wilson, R., and Barrett, J. C. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res., 57: 4667-4672, 1997.
27. Aronson, W. J., Tymchuk, C. N., Elashoff, R. M., McBride, W. H., McLean, C., Wang, H., and Heber, D. Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones. Nutr. Cancer, 35: 130-136, 1999.
28. Klein, K. A., Reiter, R. E., Redula, J., Moradi, H., Zhu, X. L., Brothman, A. R., Lamb, D. J., Marcelli, M., Belldegrun, A., Witte, O. N., and Sawyers, C. L. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat. Med., 3: 402-408, 1997.
29. Craft, N., Chhor, C., Tran, C., Belldegrun, A., DeKernion, J., Witte, O. N., Said, J., Reiter, R. E., and Sawyers, C. L. Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process. Cancer Res., 59: 5030-5036, 1999.
30. Gleave, M., Hsieh, J. T., Gao, C. A., von Eschenbach, A. C., and Chung, L. W. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res., 51: 3753-3761, 1991.
31. Cohen, P., Peehl, D. M., Baker, B., Liu, F., Hintz, R. L., and Rosenfeld, R. G. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia. J. Clin. Endocrinol. Metab., 79: 1410-1415, 1994.
32. Collett-Solberg, P. F., and Cohen, P. Genetics, chemistry, and function of the IGF/IGFBP system. Endocrine, 12: 121-136, 2000.
33. Ngo, T. H., Barnard, R. J., Tymchuk, C. N., Cohen, P., and Aronson, W. J. Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro. Cancer Causes Control, 13: 929-935, 2002.
34. Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., and Pollak, M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science, 279: 563-566, 1998.
35. Mantzoros, C. S., Tzonou, A., Signorello, L. B., Stampfer, M., Trichopoulos, D., and Adami, H. O. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br. J. Cancer, 76: 1115-1118, 1997.
36. Hsing, A. W., Chua, S., Jr., Gao, Y. T., Gentzschein, E., Chang, L., Deng, J., and Stanczyk, F. Z. Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J. Natl. Cancer Inst. (Bethesda), 93: 783-789, 2001.
37. Lehrer, S., Diamond, E. J., Stagger, S., Stone, N. N., and Stock, R. G. Increased serum insulin associated with increased risk of prostate cancer recurrence. Prostate, 50: 1-3, 2002.
38. Phillips, L. S., Harp, J. B., Goldstein, S., Klein, J., and Pao, C. I. Regulation and action of insulin-like growth factors at the cellular level. Proc. Nutr. Soc. 49: 451-458, 1990.
39. Kaytor, E. N., Zhu, J. L., Pau, C. I., Phillips, L. S. Physiologic concentrations of insulin promote binding of nuclear proteins to the insulin-like growth factor I gene. Endocrinology, 142: 1041-1049, 2001.
40. Levitt Katz, L. E., Satin-Smith, M. S., Collett-Solberg, P., Thornton, P. S., Baker, L., Stanley, C. A., and Cohen, P. Insulin-like growth factor binding protein-1 levels in the diagnosis of hypoglycemia caused by hyperinsulinism. J. Pediatr., 131: 193-199, 1997.
41. Yakar, S., Liu, J. L., Stannard, B., Butler, A., Accili, D., Sauer, B., and LeRoith, D. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc. Natl. Acad. Sci. USA, 96: 7324-7329, 1999.
42. Liu, J. L., Grinberg, A., Westphal, H., Sauer, B., Accili, D., Karas, M., and LeRoith, D. Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice. Mol. Endocrinol., 12: 1452-1462, 1998.
43. Wu, Y., Yakar, S., Zhao, L., Hennighausen, L., and LeRoith, D. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res., 62: 1030-1035, 2002.
44. Rechler, M. M., and Clemmons, D. R. Regulatory actions of insulin-like growth factor-binding proteins. Trends Endocrinol. Metab., 9: 176-183, 1998.
45. Wallace, P. IGF Binding Proteins-Mini Review, GroPep Ltd. Technical Bulletin, Vol. 8, pp. 1-5, 2001.
46. Hoeflich, A., Schmidt, P., Foll, J., Rottmann, O., Weber, M. M., Kolb, H. J., Pirchner, F., and Wolf, E. Altered growth of mice divergently selected for body weight is associated with complex changes in the growth hormone/insulin-like growth factor system. Growth Horm. IGF Res., 8: 113-123, 1998.
47. Lewitt, M. S., Saunders, H., and Baxter, R. C. Regulation of rat insulin-like growth factor-binding protein-1: the effect of insulin-induced hypoglycemia. Endocrinology, 131: 2357-2364, 1992.
48. Lee, P. D., Giudice, L. C., Conover, C. A., and Powell, D. R. Insulin-like growth factor binding protein-1: recent findings and new directions. Proc. Soc. Exp. Biol. Med., 216: 319-357, 1997.
49. Powell, D. R., Allander, S. V., Scheimann, A. O., Wasserman, R. M., Durham, S. K., and Suwanichkul, A. Multiple proteins bind the insulin response element in the human IGFBP-1 promoter. Prog. Growth Factor Res., 6: 93-101, 1995.
50. Lee, P. D., Conover, C. A., and Powell, D. R. Regulation and function of insulin-like growth factor-binding protein-1. Proc. Soc. Exp. Biol. Med., 204: 4-29, 1993.
51. Wolk, A., Mantzoros, C. S., Andersson, S. O., Bergstrom, R., Signorello, L. B., Lagiou, P., Adami, H. O., and Trichopoulos, D. Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J. Natl. Cancer Inst. (Bethesda), 90: 911-915, 1998.
52. Stattin, P., Bylund, A., Rinaldi, S., Biessy, C., Dechaud, H., Stenman, U. H., Egevad, L., Riboli, E., Hallmans, G., and Kaaks, R. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J. Natl. Cancer Inst. (Bethesda), 92: 1910-1917, 2000.
53. Tennant, M. K., Thrasher, J. B., Twomey, P. A., Birnbaum, R. S., and Plymate, S. R. Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate. J. Clin. Endocrinol. Metab., 81: 411-420, 1996.
54. Mita, K., Nakahara, M., and Usui, T. Expression of the insulin-like growth factor system and cancer progression in hormone-treated prostate cancer patients. Int. J. Urol., 7: 321-329, 2000.
55. Shariat, S. F., Lamb, D. J., Kattan, M. W., Nguyen, C., Kim, J., Beck, J., Wheeler, T. M., and Slawin, K. M. Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis. J. Clin. Oncol., 20: 833-841, 2002.
56. Cohen, P., Peehl, D. M., Stamey, T. A., Wilson, K. F., Clemmons, D. R., and Rosenfeld, R. G. Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. J. Clin. Endocrinol. Metab., 76: 1031-1035, 1993.
57. Moore, M., Wetterau, L., Francis, M., Peehl, D., and Cohen, P. A novel stimulatory role for insulin-like growth factor binding protein-2 in prostate cancer cells. Int. J. Cancer, 105: 14-19, 2003.
58. Rose, D. P., and Connolly, J. M. Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate, 18: 243-254, 1991.
59. Tjandrawinata, R. R., Dahiya, R., and Hughes-Fulford, M. Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic tadc carcinoma cells. Br. J. Cancer, 75: 1111-1118, 1997.
60. Chaudry, A. A., Wahle, K. W., McClinton, S., and Moffat, L. E. Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: effects of fatty acids and cyclooxygenase inhibitors. Int. J. Cancer, 57: 176-180, 1994.
61. Ablin, R. J., and Shaw, M. W. Prostaglandin modulation of prostate tumor growth and metastases. Anticancer Res., 6: 327-328, 1986.
62. Eling, T. E., and Glasgow, W. C. Cellular proliferation and lipid metabolism: importance of lipoxygenases in modulating epidermal growth factor-dependent mitogenesis. Cancer Metastasis Rev., 13: 397-410, 1994.
63. Honn, K. V., Tang, D. G., Gao, X., Butovich, I. A., Liu, B., Timar, J., and Hagmann, W. 12-lipoxygenases and 12(S)-HETE: role in cancer metastasis. Cancer Metastasis Rev., 13: 365-396, 1994.
64. Gupta, S., Srivastava, M., Ahmad, N., Sakamoto, K., Bostwick, D. G., and Mukhtar, H. Lipoxygenase-5 is overexpressed in prostate adenocarcinoma. Cancer, 91: 737-743, 2001.
65. Mukherjee, P., Sotnikov, A. V., Mangian, H. J., Zhou, J. R., Visek, W. J., and Clinton, S. K. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. J. Natl. Cancer Inst. (Bethesda), 91: 512-523, 1999.
66. Reeves, P. G., Nielsen, F. H., and Fahey, G. C., Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr., 123: 1939-1951, 1993.